(Q35762005)

10 August 2017

title

Intraocular pressure alterations following intravitreal triamcinolone acetonide (English)

1 reference

10 August 2017

D J Rhee

1

1 reference

10 August 2017

R E Peck

2

1 reference

10 August 2017

J Belmont

3

1 reference

10 August 2017

A Martidis

4

1 reference

10 August 2017

M Liu

5

1 reference

10 August 2017

J Chang

6

1 reference

10 August 2017

J Fontanarosa

7

1 reference

10 August 2017

M R Moster

8

1 reference

10 August 2017

language of work or name

English

0 references

publication date

5 April 2006

1 reference

British Journal of Ophthalmology

10 August 2017

published in

1 reference

10 August 2017

volume

90

1 reference

10 August 2017

issue

8

1 reference

10 August 2017

page(s)

999-1003

1 reference

Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial

10 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857192

The effect of intravitreal triamcinolone acetonide on intraocular pressure

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857192

Intravitreal triamcinolone acetonide for refractory chronic pseudophakic cystoid macular edema

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857192

Intravitreal injection of triamcinolone for diffuse diabetic macular edema

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857192

Intraocular pressure after intravitreal injection of triamcinolone acetonide

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857192

Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857192

Intraocular pressure elevation after intravitreal triamcinolone acetonide injection

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857192

Safety of intravitreal high-dose reinjections of triamcinolone acetonide

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857192

Intravitreal triamcinolone acetonide and intraocular pressure

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857192

Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857192

Intractable glaucoma following intravitreal triamcinolone in central retinal vein occlusion

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857192

Intraocular availability of triamcinolone acetonide after intravitreal injection

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857192

Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857192

Intravitreal reinjection of triamcinolone for exudative age-related macular degeneration

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857192

INTRAOCULAR PRESSURE RESPONSE TO TOPICAL CORTICOSTEROIDS

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857192

Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857192

Secondary chronic open-angle glaucoma after intravitreal triamcinolone acetonide

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857192

A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857192

Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857192

Intravitreal triamcinolone for the treatment of idiopathic juxtafoveal telangiectasis

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857192

Intravitreal triamcinolone for refractory pseudophakic macular edema.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857192

Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857192

Regression of neovascular iris vessels by intravitreal injection of crystalline cortisone

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857192

Dexamethasone ocular hypertension in the clinically normal eye. II. The untreated eye, outflow facility, and concentration

25 September 2018

1 reference

12 December 2020

CORTICOSTEROIDS AND INTRAOCULAR PRESSURE

1 reference

12 December 2020

STATISTICAL ATTRIBUTES OF THE STEROID HYPERTENSIVE RESPONSE IN THE CLINICALLY NORMAL EYE. I. THE DEMONSTRATION OF THREE LEVELS OF RESPONSE

1 reference

12 December 2020

Intraocular pressure elevation after intravitreal triamcinolone acetonide injection

1 reference

12 December 2020

Intravitreal triamcinolone and elevated intraocular pressure

1 reference

12 December 2020

Identifiers

DOI

10.1136/BJO.2006.090340

1 reference

10 August 2017

1 reference

10 August 2017

1 reference